Fabio Feroldi,1 Margherita Vaselli,1 Mariska Verlaan,2 Helene Knaus,1 Valentina Davidoiu,1 Danielle Vugts,2 Carla Molthoff,2 Guus van Dongen,2 Johannes F. de Boer1
PERSONAL Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.
Imaging the heterogeneity of the tumor microenvironment is thought to be valuable for assessing the efficacy of a cancer therapy. However, due to the insufficient resolution of clinically available molecular imaging tools such as positron emission tomography, this feat is currently not achievable. Here, we demonstrate that revealing the TME is possible with immuno-near-infrared-fluorescence (Immuno-NIRF) imaging. Moreover, we combined immuno-NIRF with optical coherence tomography (OCT) to provide structural context to the molecular images. The combination of the two techniques may represent a novel tool in the operating room for assessing development or early diagnosis of tumors.
PERSONAL Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.
The alert did not successfully save. Please try again later.
Fabio Feroldi, Margherita Vaselli, Mariska Verlaan, Helene Knaus, Valentina Davidoiu, Danielle Vugts, Carla Molthoff, Guus van Dongen, Johannes F. de Boer, "Combined structural and molecular imaging using optical coherence tomography and immunofluorescence imaging (Conference Presentation)," Proc. SPIE 11222, Molecular-Guided Surgery: Molecules, Devices, and Applications VI, 1122204 (10 March 2020); https://doi.org/10.1117/12.2545222